Abstract
Alzheimer' s Disease is the most common cause of dementia, constituting 60% to
70% of all cases, and the risk with the disease doubles every 5 years after
age 65. Incidence of the disease is increasing, and the resulting attention
given to Alzheimer' s Disease has encouraged development of new treatments.
There is an opportunity for pharmaceutical companies to compete in this
market, as Kalorama analyst Melissa Elder outlines in this study.
This report includes incidence of Alzheimer' s disease worldwide with
information for specific geographical regions; world demographics; life
expectancy by country, and other general issues affecting the market.
Information is presented as a worldwide overview, with special emphasis on the
U.S., Japan, Germany, and other key markets.
A market summary includes market analysis by products on the market and in
development, in addition to a a regional market analysis, including:
- US
- Europe
- Japan
- Rest of World
as well as a competitive analysis of leading providers. Additionally
key company profiles are included, with profiles of the following
companies competing in this therapeutic area:
- Eisai Co., Ltd.
- Forest Laboratories
- H. Lundbeck A/S
- Johnson & Johnson
- Merz Pharma GmbH
- Novartis AG
- Pfizer, Inc.
Markets are broken out by drug type:
- Cholinesterase inhibitors
- NMDA antagonists
as well as by product.
The information for this report was gathered using both primary and secondary
research including comprehensive research of secondary sources such as company
literature, databases, investment reports, and medical and business journals.
Telephone interviews and email correspondence were the primary method of
gathering information.
For the purpose of this study, Kalorama Information conducted interviews
with more than 50 key industry officials, consultants, health care providers,
and government personnel. These sources were the primary basis in
gathering information specifically relating to revenue and market share data
presented in this report. Additional interviews were completed with relevant
company representatives including marketing directors, division managers, and
product representatives.
All market data pertains to the world market at the manufacturers' level. The
base year for data was 2007. Historical data was provided for the years 2005
and 2006, with forecast data provided for 2008 through 2012. Compound annual
growth rates (CAGRs) are provided for the 2005-2007 and 2008-2012 periods for
each region and/or segment covered. Competitive analysis is provided for the
year 2007.
| 
View Cart
